Francis Medical is developing groundbreaking, disruptive therapeutic solutions to treat prostate, kidney, and bladder cancer.*
Francis Medical is a medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients. Our work is fueled by a compassionate belief that cancer can be stopped with minimally invasive treatments.
VANQUISH® – CANCER ABLATION BY WATER VAPOR
Water vapor technology, a new platform being explored for treating a variety of endourological cancers, uses the energy stored in a few drops of water to ablate cancerous tissue. The Vanquish Water Vapor Ablation System is designed to not only ablate cancer cells but also protect surrounding structures, lessening the likelihood of the life-altering side effects common with other cancer treatments.
PROSTATE CANCER
Initially, Francis Medical is focusing its efforts on prostate cancer, the second most common cancer in American men that often includes treatments with undesired side effects like urinary incontinence and erectile dysfunction. Currently available treatments often generate undesired side effects like urinary incontinence and erectile dysfunction.
Francis Medical is named after Francis Hoey, the father of inventor and Francis Medical founder Michael Hoey. In 1991, after undergoing prostate cancer treatments with debilitating effects on his daily living, Francis died from prostate cancer.
Today, the work of Francis Medical stands as a tribute to and a lasting legacy of Francis Hoey.
A Breakthrough Technology
Vanquish® Water Vapor Ablation System
Although this innovative therapy is being designed to address a variety of endourological cancers, initial efforts are focused on the treatment of prostate cancer.
Water vapor technology is designed to treat cancerous prostate tissue with the thermal energy stored in sterile water vapor. The Vanquish Water Vapor Ablation System delivers this targeted and precise application of thermal energy using a simple transurethral procedure.
Traditional prostate cancer treatments include surgery, radiation, hospital stays, and debilitating side effects such as incontinence and sexual dysfunction. In contrast, patients treated with water vapor technology should typically be able to go home the same day and resume their normal lifestyle the very next day. Learn about our VAPOR 2 clinical trial, now underway.
A Breakthrough Technology
Vanquish® Water Vapor Ablation System
Although this innovative approach is being designed to address a variety of endourological cancers, initial efforts are focused on the treatment of prostate cancer.
Water vapor technology is designed to treat cancerous prostate tissue with the thermal energy stored in sterile water vapor. The Vanquish Water Vapor Ablation System delivers this targeted and precise application of thermal energy during a simple transurethral procedure.
Traditional prostate cancer treatments include surgery, hospital stays, and debilitating side effects such as incontinence and sexual dysfunction. In contrast, patients treated with water vapor technology should typically be able to go home the same day and resume their normal lifestyle the very next day. Learn about our VAPOR 2 clinical trial, now underway.
LATEST NEWS
*CAUTION Investigational device. Limited by United States law to investigational use.
Transformational Technology
“This breakthrough technology holds the promise of minimizing the life-altering side effects commonly encountered with conventional, more aggressive prostate cancer treatments.”
